Watch HLYK. Know when insiders buy.
One email the day a filing lands. Free.
HLYK
HealthLynked Corp
2.18
+0.02 +0.88%
USD · close Sep 17
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.4MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$4MNET CASH $10K52W 1.26 – 6.15SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$539K | −$820K | — | -0.28 | −$350K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$701K | −$1.6M | — | -0.56 | −$222K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$531K | −$676K | — | -0.24 | −$419K | — | — | Mar 31 |
| Q3 2025 · Sep 30 | — | — | — | −$530K | −$852K | — | -0.30 | −$444K | — | — | Nov 19 |
| Q2 2025 · Jun 30 | — | — | — | −$435K | −$701K | — | -0.25 | −$418K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$617K | −$1.1M | — | -0.37 | −$433K | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | $619K | −33.5% | — | −$749K | −$1.2M | — | -0.44 | −$744K | $0 | −$744K | Mar 31 |
| Q3 2024 · Sep 30 | $590K | −55.7% | — | −$1.7M | −$2M | — | -0.70 | −$1M | $0 | −$1M | Nov 19 |
| Q2 2024 · Jun 30 | $795K | — | — | −$1.1M | −$1.5M | — | -0.01 | −$859K | $0 | −$859K | Nov 19 |
| Q1 2024 · Mar 31 | $1M | — | — | −$1.2M | −$1.4M | — | 0.00 | −$855K | $3K | −$857K | Nov 19 |
| Q4 2023 · Dec 31derived | $931K | — | — | −$1.1M | −$1.3M | — | 0.00 | −$1.2M | $0 | −$1.2M | Mar 31 |
| Q3 2023 · Sep 30 | $1.3M | — | — | −$1.2M | −$175K | — | 0.00 | −$1.2M | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$2.1M | −$3.3M | — | -1.16 | −$1.7M | — | — | — | — |
| FY2024 · to Dec 31 | $3M | — | −$4.7M | −$6.1M | -203.8% | -2.18 | −$3.5M | $3K | −$3.5M | — | — |
| FY2023 · to Dec 31 | $5.7M | — | −$4.2M | −$1M | -17.7% | 0.00 | −$4.1M | $2K | −$4.1M | — | — |
| FY2022 · to Dec 31 | $5.9M | — | −$8.7M | −$8.8M | -150.5% | -0.04 | −$4.4M | $24K | −$4.4M | — | — |
| FY2021 · to Dec 31 | $6.5M | — | −$5.3M | −$10.4M | -160.3% | -0.05 | −$3.8M | $19K | −$3.8M | $8K | — |
| FY2020 · to Dec 31 | $6.1M | — | −$3.1M | −$5.8M | -93.8% | -0.04 | −$2.1M | $25K | −$2.1M | — | — |
Every number comes from HealthLynked Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.